Lithrocal Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

K citrate

Indications/Uses

Management of renal tubular acidosis w/ Ca stones, hypocitraturic Ca oxalate nephrolithiasis of any etiology & uric acid lithiasis w/ or w/o Ca stones.

Click to view Lithrocal detailed prescribing information

Dosage/Direction for Use

Patient w/ severe hypocitraturia (urinary citrate <150 mg/day) Initially 60 mEq/day (20 mEq tid or 15 mEq qid). Patient w/ mild to moderate hypocitraturia (>150 mg/day) Initially 30 mEq/day (10 mEq tid). Use 24 hr urinary citrate &/or urinary pH measurements to determine adequacy of initial dosage & to evaluate effectiveness of any dosage change. Measure urinary citrate &/or pH every 4 mth.

Click to view Lithrocal detailed prescribing information

Administration

Should be taken with food.

Contraindications

Hyperkalemia or conditions predisposing to hyperkalemia eg, chronic renal failure, uncontrolled DM, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown. Concomitant use w/ K-sparing agent eg, triamterene, spironolactone or amiloride; anticholinergic medication. Patient suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or structure. PUD. Renal insufficiency (GFR <0.7 mL/kg/min).

Click to view Lithrocal detailed prescribing information

Special Precautions

Patients w/ impaired mechanisms for excreting K. Avoid in patients w/ chronic renal failure or any other conditions which impair K excretion eg, severe myocardial damage or heart failure. Discontinue immediately if severe vomiting, abdominal pain or GI bleeding occurs & investigate possibility of bowel perforation or obstruction.

Click to view Lithrocal detailed prescribing information

Adverse Reactions

Abdominal discomfort, vomiting, diarrhea, loose bowel movements or nausea.

Click to view Lithrocal detailed prescribing information

Drug Interactions

Severe hyperkalemia w/ K-sparing diuretic (eg, triamterene, spironolactone or amiloride).

Click to view Lithrocal detailed prescribing information

Storage

View Lithrocal storage conditions for details to ensure optimal shelf-life.

Description

View Lithrocal description for details of the chemical structure and excipients (inactive components).

Action

View Lithrocal mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

A12BA02 - potassium citrate ; Belongs to the class of potassium-containing preparations. Used as dietary supplements.

Regulatory Classification

Presentation/Packing

Form

Lithrocal ER tab 1,080 mg

Packing/Price

30's (P10/ER tab, P300/box)

Lithrocal

potassium citrate

Manufacturer:

Cooper Pharma

Distributor:

Distriphil